Homepage Top Section2

VIR-7832, a neutralising Covid-19 antibody, attaches to an epitope on SARS-CoV-2 that is shared with SARS-CoV-1. According to GSK, the preclinical data suggests that VIR-7832 has two distinguishing

As per terms of the deal, Kymab will secure an upfront payment of up to $1.1bn from Sanofi. Kymab is also eligible to secure up to $350m based

The company has pooled funds in a financing round co-led by new investors Rock Springs Capital and Foresite Capital. Other new investors consist of T. Rowe Price, Wellington

As per terms of the deal, Bayer will extend its support for further development, supply and crucial territory operations of CureVac´s Covid-19 vaccine candidate. By the end of

Fujifilm stated that it is establishing the new manufacturing site to boost the growth of its biopharmaceutical contract development and manufacturing business (CDMO). The company’s subsidiary Fujifilm Diosynth

The breakthrough therapy designation allows the combination therapy as a first-line treatment for people with metastatic NSCLC whose tumours have high PD-L1 expression with no EGFR or ALK

Arvelle Therapeutics is involved in the development of advanced solutions to treat patients suffering from central nervous system (CNS) disorders. The company is currently engaged in the development

Under the terms of the proposed agreement, the company will commence distribution of the vaccine in the second quarter of 2021. The Moderna COVID-19 vaccine has not been

Expected to improve competition and access to more affordable medicines, the approval has been given to the first generic of glucagon for injection USP, 1 mg/vial packaged in